References
1
Schwindt MA.
Belmont DT.
Carlson M.
Franklin LC.
Hendrickson VS.
Karrick GL.
Poe RW.
Sobieray DM.
Van de Vusse J.
J. Org. Chem.
1996,
61:
9564
2a
Pirrung MC.
Shuey SW.
J. Org. Chem.
1994,
59:
3890
2b
Ohta S.
Yamashita M.
Arita K.
Kajiura T.
Kawasaki I.
Noda K.
Izumi M.
Chem. Pharm. Bull.
1995,
43:
1294
3a
Lu Y.
Miet C.
Kunesch N.
Poisson JE.
Tetrahedron: Asymmetry
1993,
4:
893
3b
Brown RFC.
Donohue AC.
Jackson WR.
McCarthy TD.
Tetrahedron
1994,
50:
13739
3c
Zhao X.
Wan X.
Org. Prep. Proced. Int.
1995,
27:
513
4a
Jackson WR.
Jacobs HA.
Matthews BR.
Jayatilake GS.
Watson KG.
Tetrahedron Lett.
1990,
31:
1447
4b
Tellitu I.
Badía D.
Domínguez E.
García FJ.
Tetrahedron: Asymmetry
1994,
5:
1567
4c
Effenberger F.
Eichhorn J.
Tetrahedron: Asymmetry
1997,
8:
469
5
Gaucher A.
Ollivier J.
Salaín J.
Synlett
1991,
151
6
Parisi MF.
Gattuso G.
Notti A.
Raymo FM.
J. Org. Chem.
1995,
60:
5174
7
Effenberger F.
Stelzer U.
Angew. Chem., Int. Ed. Engl.
1991,
30:
873
8
Stelzer U.
Effenberger F.
Tetrahedron: Asymmetry
1993,
4:
161
9
Syed J.
Furster S.
Effenberger F.
Tetrahedron: Asymmetry
1998,
9:
805
10
Monterde MI.
Brieva R.
Gotor V.
Tetrahedron: Asymmetry
2001,
12:
525
11
Monterde MI.
Nazabadioko S.
Rebolledo F.
Brieva R.
Gotor V.
Tetrahedron: Asymmetry
1999,
10:
3449
12a
North M.
Synlett
1993,
807
12b
Effenberger F.
Angew. Chem., Int. Ed. Engl.
1994,
33:
1555
12c
Gregory RJH.
Chem. Rev.
1999,
99:
3649
12d
North M.
Tetrahedron: Asymmetry
2003,
14:
147
13a
Ryu DH.
Corey EJ.
J. Am. Chem. Soc.
2004,
126:
8106
13b
Ryu DH.
Corey EJ.
J. Am. Chem. Soc.
2005,
127:
5384
14a
Hamashima Y.
Sawada D.
Kanai M.
Shibasaki M.
J. Am. Chem. Soc.
1999,
121:
2641
14b
Takamura M.
Funabashi K.
Kanai M.
Shibasaki M.
J. Am. Chem. Soc.
2000,
122:
6327
14c
Shibasaki M.
Yoshikawa N.
Chem. Rev.
2002,
102:
2187
15a
Kanai M.
Tomioka K.
Tetrahedron Lett.
1995,
36:
4271
15b
Kanai M.
Tomioka K.
Tetrahedron Lett.
1995,
36:
4275
16
Trost BM.
Yeh VSC.
Ito H.
Bremeyer N.
Org. Lett.
2002,
4:
2621
17a
Kim YH.
Acc. Chem. Res.
2001,
34:
955
17b
Kim SM.
Byun IS.
Kim YH.
Angew. Chem. Int. Ed.
2000,
39:
728
18
2,6-Bis[2-(diphenylphosphinoylmethyl)octahydroindol-1-ylmethyl]-4-methylphenol(7); Typical Procedure
2,6-Bis(bromomethyl)-4-methylphenol (292 mg, 1 mmol) was added in one portion to a stirred and cooled solution of 2-(diphenylphosphinoylmethyl)octahydroindole (879 mg, 2 mmol) and K2CO3 (552 mg, 4 mmol) in anhyd DMF (5 mL). The ice bath was removed after the addition and the resulting solution was allowed to stir at r.t. for 24 h before it was diluted with H2O and Et2O. The two phases were separated and the aqueous phase was extracted with Et2O three times and the combined organic phases were washed H2O, brine, dried over MgSO4, and evaporated. The residue was purified by chromatography through a short slica gel column (EtOAc-hexane, 1:1) to give 7 in 64% yield (520 mg, yellow foam). [α]D
23 -79.8 (c 1, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.42-1.60 (m, 8 H), 1. 65-1.96 (m, 4 H), 2.06 (d, 2 H), 2.08-2.34 (m, 6 H), 2.12 (s, 3 H), 2.36 (t, 2 H), 2.84-2.93 (m, 4 H), 3.28 (d, 2 H), 3.38 (d, 2 H), 3.52 (s, 2 H), 3.96 (s, 2 H), 6.75 (s, 2 H), 7.31-7.38 (m, 10 H), 7.39-7.64 (m, 10 H). 13C NMR (75.5 MHz, CDCl3): δ = 20.36, 21.97, 31.34, 31.77, 32.92, 33.63, 52.50, 53.15, 53.54, 59.40, 60.00, 123.1, 128.6, 129.6, 129.7, 131.5, 135.0, 155.3. 31P NMR (121.5 MHz, CDCl3): δ = 29.31 (s). MS (MALDI-TOF): m/z calcd for C51H60N2O3P2, 810.4079; found, 811.0474.
19
Asymmetric Cyanosilylation of Aldehydes (Table 4, entry 2); Typical Procedure
To a solution of 7 (20.2 mg, 0.025 mmol) and O=PPh3 (139 mg, 0.5 mmol) in CH2Cl2 (5 mL), Ti(Oi-Pr)4 (1 M in toluene, 25 µL, 0.025 mmol) was added at r.t., and the mixture was stirred at 0 °C for 30 min under an argon atmosphere. To this solution, benzaldehyde (0.25 mol) was added after the addition of TMSCN (60 µL, 0.5 mmol) in CH2Cl2 (1 mL) at -20 °C. The reaction was monitored by TLC, after 24 h, the mixture was concentrated and then purified by silica gel chromatography (EtOAc-hexane, 1:4) to obtain phenyltrimethylsilanyloxyacetonitrile in 74% yield. 1H NMR (300 MHz, CDCl3): d = 0.08 (s, 9 H), 5.55 (s, 1 H), 7.40-7.60 (m, 5 H). After conversion to acetate, the enantiomeric excess was determined by HPLC on a Chiralcel OD column, hexane-i-PrOH, 99:1 (flow rate = 1.0 mL/min), t
R (R) 12.92 min (major), t
R (S) 14.80 min (minor).